Domain Therapeutics SA
Records under this name other than the patents Domain Therapeutics SA holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 5 of 5 · Back to Domain Therapeutics SA
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,194,051 | 5-Azaindazole Derivatives as Adenosine Receptor Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 11,008,323 | Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group II metabotropic glutamate receptors Formerly held Lapsed on the fee record Ended May 18, 2025 · USPTO record | Lapsed on the fee record | Ended May 18, 2025 | USPTO record |
| US 10,221,179 | Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors Lapsed on the fee record Ended Mar 5, 2023 · USPTO record | Lapsed on the fee record | Ended Mar 5, 2023 | USPTO record |
| US 8,962,627 | Oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors Formerly held Lapsed on the fee record Ended Feb 24, 2023 · USPTO record | Lapsed on the fee record | Ended Feb 24, 2023 | USPTO record |
| US 9,434,734 | Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors Lapsed on the fee record Ended Sep 6, 2020 · USPTO record | Lapsed on the fee record | Ended Sep 6, 2020 | USPTO record |